Table 1. Percent of Fas and Fas-L... | American Society of Hematology

Table 1.

Percent of Fas and Fas-L expression on bone marrow plasma cells and erythroblasts

		Patients^*	Isotype of the M component	Phenotype analysis of marrow cells (% of positivity)				Peripheral Hb levels (g/dL)
				CD38⁺		Glycophorin A⁺
				Fas⁺	Fas-L⁺	Fas⁺	Fas-L⁺
		1	IgGκ	34.5	8.0	9.8	11.8	13.8
		2	IgGκ	39.8	13.7	12.6	17.0	14.1
MGUS		3	IgGλ	43.1	5.7	10.8	14.3	13.2
		4	IgAκ	30.5	6.2	11.6	13.3	12.9
		5	IgGλ	26.7	ND	10.5	18.4	14.0
	IA	1	IgAλ	46.8	15.7	21.5	15.6	12.8
		2	IgGκ	36.4	19.0	12.4	23.1	13.2
		3	IgGλ	21.4	ND	25.5	ND	13.0
		4	IgGκ	31.0	11.5	19.0	18.3	14.1
		5	BJ-κ	41.5	9.5	18.6	ND	12.3
	IIA	6	IgGκ	38.0	11.0	20.5	10.2	11.8
		7^†	IgGκ	18.2	32.3	9.8	ND	9.6
		8	IgGκ	39.5	21.4	18.0	18.5	14.0
		9	IgGλ	43.8	ND	27.7	9.2	12.6
MM stage	IIIA	10	IgAκ	21.0	33.2	31.0	11.3	9.2
		11	BJ-λ	24.5	31.3	22.5	4.4	10.1
		12	IgGκ	15.4	26.0	18.4	2.0	7.2
		13	IgGκ	33.2	ND	36.6	ND	6.8
	IIIB	14^†	IgAκ	21.4	38.5	39.8	0	6.4
		15	IgGλ	10.1	29.3	29.0	5.4	9.0
		16	IgGκ	3.0	64.2	41.5	2.5	6.5
		17	IgGκ	8.5	56.0	36.3	6.0	7.1
		18^†	IgGκ	6.3	48.6	40.6	9.1	8.2
		19^†	IgGλ	9.0	51.5	31.4	6.8	7.8

		Patients^*	Isotype of the M component	Phenotype analysis of marrow cells (% of positivity)				Peripheral Hb levels (g/dL)
				CD38⁺		Glycophorin A⁺
				Fas⁺	Fas-L⁺	Fas⁺	Fas-L⁺
		1	IgGκ	34.5	8.0	9.8	11.8	13.8
		2	IgGκ	39.8	13.7	12.6	17.0	14.1
MGUS		3	IgGλ	43.1	5.7	10.8	14.3	13.2
		4	IgAκ	30.5	6.2	11.6	13.3	12.9
		5	IgGλ	26.7	ND	10.5	18.4	14.0
	IA	1	IgAλ	46.8	15.7	21.5	15.6	12.8
		2	IgGκ	36.4	19.0	12.4	23.1	13.2
		3	IgGλ	21.4	ND	25.5	ND	13.0
		4	IgGκ	31.0	11.5	19.0	18.3	14.1
		5	BJ-κ	41.5	9.5	18.6	ND	12.3
	IIA	6	IgGκ	38.0	11.0	20.5	10.2	11.8
		7^†	IgGκ	18.2	32.3	9.8	ND	9.6
		8	IgGκ	39.5	21.4	18.0	18.5	14.0
		9	IgGλ	43.8	ND	27.7	9.2	12.6
MM stage	IIIA	10	IgAκ	21.0	33.2	31.0	11.3	9.2
		11	BJ-λ	24.5	31.3	22.5	4.4	10.1
		12	IgGκ	15.4	26.0	18.4	2.0	7.2
		13	IgGκ	33.2	ND	36.6	ND	6.8
	IIIB	14^†	IgAκ	21.4	38.5	39.8	0	6.4
		15	IgGλ	10.1	29.3	29.0	5.4	9.0
		16	IgGκ	3.0	64.2	41.5	2.5	6.5
		17	IgGκ	8.5	56.0	36.3	6.0	7.1
		18^†	IgGκ	6.3	48.6	40.6	9.1	8.2
		19^†	IgGλ	9.0	51.5	31.4	6.8	7.8

ND indicates not done.

Numbers refer to patients forming the MGUS or the MM groups.

Patients receiving chemotherapy.